Compare Macerich Company (The) Common Stock (MAC) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Macerich Company (The) Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Macerich Company (The) Common Stock trades at $22.18 (market cap $6.39B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Macerich Company (The) Common Stock is far larger — about 4.3× uniQure N.V. Ordinary Shares's market cap, and Macerich Company (The) Common Stock pays a 3.02% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Macerich Company (The) Common Stock for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| MAC | QURE | |
|---|---|---|
Market Cap | $6.39B | $1.48B |
Volume | 2,684,151 | 2,488,780 |
Sector | Real Estate | Health |
52-Week High | $26.51 | $70.59 |
52-Week Low | $16.20 | $9.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.07B | $728.62M |
Dividend Yield | 3.02% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Macerich Company (The) Common Stock
The Macerich Company is a real estate investment trust that owns, operates, and redevelops shopping centers concentrated in California, the Pacific Northwest, and other major US markets.
Read more on MAC →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
